Cargando…

Decrease of Let-7f in Low-Dose Metronomic Paclitaxel Chemotherapy Contributed to Upregulation of Thrombospondin-1 in Breast Cancer

Low-dose metronomic (LDM) paclitaxel therapy displayed a stronger anti-angiogenic activity on breast tumors with fewer side effects. Upregulation of anti-angiogenic factor Thrombospondin-1 (TSP-1) accords for therapeutic potency of LDM paclitaxel, but its molecular mechanism has not been elucidated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tao, Wei-Yang, Liang, Xiao-Shuan, Liu, Yang, Wang, Chun-Yang, Pang, Da
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278254/ https://www.ncbi.nlm.nih.gov/pubmed/25552929 http://dx.doi.org/10.7150/ijbs.9969

Ejemplares similares

Maintenance chemotherapy in children with ALL exerts metronomic-like thrombospondin-1 associated anti-endothelial effect
por: Andre, Nicolas, et al.
Publicado: (2015)

Weekly paclitaxel as metronomic palliative chemotherapy in small cell lung cancer
por: Noronha, Vanita, et al.
Publicado: (2016)

Metronomic chemotherapy
por: Maiti, Rituparna
Publicado: (2014)

Metronomic Chemotherapy
por: Cazzaniga, Marina Elena, et al.
Publicado: (2021)

Circ-ABCB10 Contributes to Paclitaxel Resistance in Breast Cancer Through Let-7a-5p/DUSP7 Axis
por: Yang, Weiping, et al.
Publicado: (2020)

Can a rational design for metronomic chemotherapy dosing be devised?
por: Maraveyas, A, et al.
Publicado: (2005)

Metronomic Chemotherapy in Prostate Cancer
por: Wysocki, Piotr J., et al.
Publicado: (2022)

Low‐dose metronomic chemotherapy improves tumor control in nasopharyngeal carcinoma
por: Chen, Yu‐Pei, et al.
Publicado: (2022)

Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin
por: Dessai, S. B., et al.
Publicado: (2016)

Metronomic and single high-dose paclitaxel treatments produce distinct heterogenous chemoresistant cancer cell populations
por: Mejia Peña, Carolina, et al.
Publicado: (2023)

Head and neck cancer: metronomic chemotherapy
por: De Felice, Francesca, et al.
Publicado: (2015)

Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial
por: Pannier, Diane, et al.
Publicado: (2018)

Nail alterations as a surrogate marker for the efficacy of low-dose metronomic chemotherapy
por: KIBATA, KAYOKO, et al.
Publicado: (2013)

Decreased let-7b is associated with poor prognosis in glioma
por: Zhang, Wanzeng, et al.
Publicado: (2019)

Combining low-dose or metronomic chemotherapy with anticancer vaccines: A therapeutic opportunity for lymphomas
por: Sheng Sow, Heng, et al.
Publicado: (2013)

Metronomic chemotherapy: changing the paradigm that more is better
por: Scharovsky, O.G., et al.
Publicado: (2009)

Response assessment in metronomic chemotherapy: RECIST or PERCIST?
por: Agrawal, Archi, et al.
Publicado: (2014)

Metronomic palliative chemotherapy in maxillary sinus tumor
por: Patil, Vijay M., et al.
Publicado: (2016)

Metronomic chemotherapy for triple negative breast cancer?
por: Di Desidero, Teresa, et al.
Publicado: (2016)

Emodin Inhibits the Indoxyl Sulfate-Induced trans-Differentiation of Vascular Smooth Muscle Cells through Upregulating Thrombospondin-1
por: Zhang, Weidong, et al.
Publicado: (2023)

Bevacizumab with metronomic chemotherapy of low-dose oral cyclophosphamide in recurrent cervical cancer: Four cases
por: Isono-Nakata, Rose, et al.
Publicado: (2018)

Metronomic chemotherapy offsets HIFα induction upon maximum‐tolerated dose in metastatic cancers
por: Schito, Luana, et al.
Publicado: (2020)

Synergy Between Low Dose Metronomic Chemotherapy and the pH-Centered Approach Against Cancer
por: Koltai, Tomas, et al.
Publicado: (2019)

Efficacy and safety of neoadjuvant chemotherapy (NACT) with paclitaxel plus carboplatin and oral metronomic chemotherapy (OMCT) in patients with technically unresectable oral squamous cell carcinoma (OSCC)
por: Kashyap1, Lakhan, et al.
Publicado: (2021)

Integrated Analysis of Differentially Expressed miRNAs and mRNAs in Goat Skin Fibroblast Cells in Response to Orf Virus Infection Reveals That cfa-let-7a Regulates Thrombospondin 1 Expression
por: Pang, Feng, et al.
Publicado: (2020)

An anti-let-7 sponge decoys and decays endogenous let-7 functions
por: Yang, Xiangling, et al.
Publicado: (2012)

Metronomic oral paclitaxel shows anti-tumor effects in an orthotopic mouse model of ovarian cancer
por: Hahn, Ho-Suap, et al.
Publicado: (2014)

miR-let-7b and miR-let-7c suppress tumourigenesis of human mucosal melanoma and enhance the sensitivity to chemotherapy
por: Tang, Huan, et al.
Publicado: (2019)

Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate
por: Dickinson, P D, et al.
Publicado: (2012)

Use of metronomic chemotherapy in the management of a cat with abdominal haemangiosarcoma
por: Yee-Ka Cheng, Katrina, et al.
Publicado: (2018)

Anti-Angiogenic Effect of Orally Available Pemetrexed for Metronomic Chemotherapy
por: Maharjan, Ruby, et al.
Publicado: (2019)

Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
por: Perroud, Herman Andrés, et al.
Publicado: (2017)

Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
por: Kim, Do Young
Publicado: (2017)

Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience
por: Simsek, Cem, et al.
Publicado: (2019)

Metronomic Chemotherapy for Palliative Treatment of Malignant Oral Tumors in Dogs
por: Milevoj, Nina, et al.
Publicado: (2022)

Metronomic Chemotherapy for Advanced Prostate Cancer: A Literature Review
por: Parshad, Shruti, et al.
Publicado: (2022)

Durable effect of imatinib and metronomic chemotherapy with capecitabine in pancreatic carcinoma
por: Al-Sukhun, Sana, et al.
Publicado: (2023)

Metronomic chemotherapy for indolent T‐cell lymphoproliferative disorder of the gastrointestinal tract
por: Liu, Hailing, et al.
Publicado: (2023)

Decreased expression of let-7c is associated with non-response of muscle-invasive bladder cancer patients to neoadjuvant chemotherapy
por: Vinall, Ruth L., et al.
Publicado: (2016)

Decreased serum levels of thrombospondin‐1 in female depressed patients
por: Okada‐Tsuchioka, Mami, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_srfdtta1c50e1630fl3q7nmf8j